GLUE - CIK 0001826457
Monte Rosa Therapeutics, Inc. has filed 352 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (112 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2024-05-09 | 2024-03-31 |
| Major company event | 8-K | 2024-05-09 | 2024-05-09 |
| Major company event | 8-K | 2024-05-02 | 2024-04-29 |
| Insider sale notice | 144 | 2024-05-01 | - |
| Annual report to shareholders | ARS | 2024-04-26 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-26 | - |
| Proxy statement | DEF 14A | 2024-04-26 | 2024-04-26 |
| Insider sale notice | 144 | 2024-04-10 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-04-10 | - |
| Employee stock plan | S-8 | 2024-03-14 | - |
| Annual report | 10-K | 2024-03-14 | 2023-12-31 |
| Major company event | 8-K | 2024-03-14 | 2024-03-14 |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Major company event | 8-K | 2024-01-08 | 2024-01-08 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Activist ownership stake (update) | SC 13D/A | 2023-11-09 | - |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Major company event | 8-K | 2023-10-26 | 2023-10-26 |
| Prospectus supplement | 424B5 | 2023-10-26 | - |
| Major company event | 8-K | 2023-10-17 | 2023-10-16 |
| New insider ownership | 3 | 2023-08-18 | 2023-08-08 |
| Insider sale notice | 144 | 2023-08-15 | - |
| Quarterly report | 10-Q | 2023-08-10 | 2023-06-30 |
| Major company event | 8-K | 2023-08-10 | 2023-08-10 |
| Insider trade | 4 | 2023-07-26 | 2023-07-25 |
| New insider ownership | 3 | 2023-07-26 | 2023-07-25 |
| Major company event | 8-K | 2023-07-26 | 2023-07-26 |
| Insider trade | 4 | 2023-06-15 | 2023-06-14 |
| Insider trade | 4 | 2023-06-15 | 2023-06-14 |
| Insider trade | 4 | 2023-06-15 | 2023-06-14 |
| Insider trade | 4 | 2023-06-15 | 2023-06-14 |
| Insider trade | 4 | 2023-06-15 | 2023-06-14 |
| Insider trade | 4 | 2023-06-15 | 2023-06-14 |
| Major company event | 8-K | 2023-06-14 | 2023-06-14 |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Annual report to shareholders | ARS | 2023-04-26 | 2022-12-31 |
| Proxy materials | DEFA14A | 2023-04-26 | - |
| Proxy statement | DEF 14A | 2023-04-26 | 2023-04-26 |
| PRE 14A | - | 2023-04-12 | 2023-04-12 |